Gliatech aims for ADCON-L relaunch on US market
This article was originally published in Clinica
Executive Summary
Gliatech, which has had a troubled few years with the recall of its anti-adhesive gel ADCON-L and a failed merger attempt, has been told by the FDA of the necessary steps to get its product back on the US market. The Cleveland, Ohio company has also announced plans for a proposed rights issue.